Crystal Pietranton, NP
Family · Wheeling, WVNPI 1922451459
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 66.4% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $7,205, 10.0 times the $723 reported in 2021. Among family clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $97.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Medtronic$833
- Boston Scientific$749
- Edwards Lifesciences$461
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$365
- AstraZeneca$170
- plus $591 from 11 others
What the payments were for
- Consulting fees$4,92552%
- Travel & lodging$1,57817%
- Food & beverage$2,90531%
- Education$270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 26 | $6,265 |
| Medtronic | 12 | $833 |
| Boston Scientific | 10 | $749 |
| Edwards Lifesciences | 6 | $461 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 20 | $365 |
| AstraZeneca | 8 | $170 |
| E.r. Squibb & Sons, L.L.C. | 2 | $159 |
| Abiomed | 1 | $136 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $65 |
| Cerus Corporation | 1 | $47 |
| Actelion Pharmaceuticals US, Inc. | 2 | $39 |
| Cvrx, Inc. | 2 | $34 |
| Novartis | 2 | $31 |
| Heartflow, Inc. | 1 | $24 |
| Novo Nordisk | 1 | $22 |
| W. L. Gore & Associates, Inc. | 1 | $19 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,435 in reported general payments places this provider in the 95th percentile of 1,507 family providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 95 | $138,557 |
| JardianceEmpagliflozin | 63 | $77,824 |
| FarxigaDapagliflozin Propanediol | 57 | $60,932 |
| EliquisApixaban | 61 | $53,400 |
| Valsartan | 75 | $1,872 |
| ClopidogrelClopidogrel Bisulfate | 147 | $1,693 |
| Metoprolol Succinate | 89 | $1,090 |
| Amiodarone Hcl | 28 | $684 |
| Furosemide | 76 | $407 |
| Spironolactone | 58 | $358 |
| Amlodipine Besylate | 13 | $153 |
| Carvedilol | 29 | $152 |
| Hydralazine Hcl | 11 | $150 |
| Lisinopril | 30 | $134 |
| Atorvastatin Calcium | 14 | $113 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $31 | $138,55795 claims |
| AstraZenecaFarxiga | $170 | $60,93257 claims |
| PfizerEliquis | $14 | $53,40061 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,507 family providers in West Virginia.
Other family in Wheeling
- Martha DonahueWheeling$11K
- Beverly LoewWheeling$9K
- Abigail CrummittWheeling$9K
- Suzanne FigurskiWheeling$8K
- Ashley ComerCharleston$213K
- Dana CruseParkersburg$109K
- Sarah KnightCharleston$99K
- Star RoeBarboursville$55K
- Angela SettleCharleston$51K
- Amber DuncanCross Lanes$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.